EpiVax Announces Publication of Antigen-Specific Tolerance Ind...
PROVIDENCE, Rhode Island, Nov. 6, 2019 /PRNewswire-AsiaNet/ -- EpiVax, Inc. ("EpiVax"), a pioneer in immunoinformatics innovation, announces the publication of "Therapeutic administration of Tregitope-Human Albumin Fusion with Insulin Peptides to promote Antigen-Specific Adaptive Tolerance Induction" in Scien...
Authors: LATEST ASIANET NEWS RELEASES